India · Delayed Price · Currency is INR Suven Life Sciences Statistics
Total Valuation
BOM:530239 has a market cap or net worth of INR 35.02 billion. The enterprise value is 32.45 billion.
| Market Cap | 35.02B |
| Enterprise Value | 32.45B |
Important Dates
The last earnings date was Thursday, January 29, 2026.
| Earnings Date | Jan 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:530239 has 231.95 million shares outstanding. The number of shares has increased by 2.12% in one year.
| Current Share Class | 231.95M |
| Shares Outstanding | 231.95M |
| Shares Change (YoY) | +2.12% |
| Shares Change (QoQ) | +0.83% |
| Owned by Insiders (%) | 2.13% |
| Owned by Institutions (%) | 38.82% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 495.99 |
| PB Ratio | 12.45 |
| P/TBV Ratio | 12.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.81 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -1,188.91% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.50% |
| Revenue Per Employee | 511,710 |
| Profits Per Employee | -19.91M |
| Employee Count | 138 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +30.23% in the last 52 weeks. The beta is 0.23, so BOM:530239's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | +30.23% |
| 50-Day Moving Average | 158.66 |
| 200-Day Moving Average | 203.84 |
| Relative Strength Index (RSI) | 49.09 |
| Average Volume (20 Days) | 26,994 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:530239 had revenue of INR 70.62 million and -2.75 billion in losses. Loss per share was -12.35.
| Revenue | 70.62M |
| Gross Profit | 63.10M |
| Operating Income | -2.83B |
| Pretax Income | -2.75B |
| Net Income | -2.75B |
| EBITDA | -2.78B |
| EBIT | -2.83B |
| Loss Per Share | -12.35 |
Balance Sheet
The company has 2.57 billion in cash and n/a in debt, with a net cash position of 2.57 billion or 11.10 per share.
| Cash & Cash Equivalents | 2.57B |
| Total Debt | n/a |
| Net Cash | 2.57B |
| Net Cash Per Share | 11.10 |
| Equity (Book Value) | 2.81B |
| Book Value Per Share | 12.66 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 89.36% |
| Operating Margin | -4,002.84% |
| Pretax Margin | -3,889.96% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BOM:530239 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.12% |
| Shareholder Yield | -2.12% |
| Earnings Yield | -7.84% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 23, 2007. It was a forward split with a ratio of 4.
| Last Split Date | Mar 23, 2007 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |